Biotech News - Congoohttp://www.congoo.com/feed/newschannelsfeed.aspx?chid=22&catid=134News Feed for - BiotechPicksThatMove.com Announces Investment Opinion on Ivernia Inc., Weatherford International http://www.congoo.com/news/addstorycomment.aspx?st=96503550&Channel_ID=22&Category_ID=1342009-11-26T01:24:00BusinessWire - PicksThatMove is pleased to bring investors special situation stocks which have a high potential for price appreciation. These companies have interesting business models and they have to Forbes.comAnadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conferencehttp://www.congoo.com/news/addstorycomment.aspx?st=96393844&Channel_ID=22&Category_ID=1342009-11-26T05:34:00SAN DIEGO, Nov. 24 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will present at the 21st Annual Piper Jaffray Healthcare Conference on Tuesday, December KOTA Territory NewsOpponents of GM crops are motivated by "emotion" not scientific reasonhttp://www.congoo.com/news/addstorycomment.aspx?st=96548906&Channel_ID=22&Category_ID=1342009-11-26T07:34:00Opponents of GM food are motivated by emotion and ideology rather than a reasoned scientific approach, according to a major report by a government funded quango. The study, which states one of its aims TelegraphGM crop sceptics 'emotional', Government food watchdog report claimshttp://www.congoo.com/news/addstorycomment.aspx?st=96547271&Channel_ID=22&Category_ID=1342009-11-26T07:00:00Public opposition to genetically modified food is based on ??emotion? rather than ??reason?, a Food Standards Agency report which will help shape future Government policy claims. The study published TelegraphGenzyme CEO sells 200,000 of company's shareshttp://www.congoo.com/news/addstorycomment.aspx?st=96504970&Channel_ID=22&Category_ID=1342009-11-26T01:10:00BANGALORE (Reuters) - Biotechnology company Genzyme Corp's Chief Executive Henri Termeer sold 200,000 shares of the company for $50.47 apiece on Nov. 23, according to a regulatory filing. In the filing Reuters HealthGenome-wide gene regulation of biosynthesis and energy generation by a novel transcriptional http://www.congoo.com/news/addstorycomment.aspx?st=96545983&Channel_ID=22&Category_ID=1342009-11-26T06:34:00Mono-ubiquitylation of a transactivator is known to promote transcriptional activation of certain transactivator proteins. For the Sacchromyces cerevisiae transactivator, GAL4, attachment of mono-ubiquitin Bioscience Technology OnlineGSK, Gilead enter licensing pact to commercialise HB V drug Viread in 5 Asian countrieshttp://www.congoo.com/news/addstorycomment.aspx?st=96449039&Channel_ID=22&Category_ID=1342009-11-26T05:27:00GlaxoSmithKline (GSK) and Gilead Sciences, Inc announced a licensing agreement to commercialise Viread (tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B (HBV) infection in adults PharmaBizUPS and Genzyme are about to go live on a California- and GS1-compliant track-and-trace http://www.congoo.com/news/addstorycomment.aspx?st=96535457&Channel_ID=22&Category_ID=1342009-11-26T04:41:00UPS gets ready to receive GS1 product-tracking data from anyone Give the parties involved in this project this credit: they stuck to their guns. UPS Healthcare Logistics (Atlanta), Genzyme (Cambridge, Pharmaceutical CommerceGenome Analysis Centre issues capacity and capability challengehttp://www.congoo.com/news/addstorycomment.aspx?st=96514455&Channel_ID=22&Category_ID=1342009-11-26T00:29:00Cambridge Network keeps you informed of all the latest news from Cambridge and beyond. News articles posted on our site by our members are picked up by Search engines and News Services such as GoogleNews Cambridge NetworkEmerging Stock Report Initiates Independent Research Coverage on Bryn Resources http://www.congoo.com/news/addstorycomment.aspx?st=96471293&Channel_ID=22&Category_ID=1342009-11-26T01:54:00Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on Bryn Resources Inc. (Pink Sheets:BRYN). Emerging Stock Report is currently offering Individual.comOncolytics Biotech Inc. Closes US$12.75 Million Unit Offeringhttp://www.congoo.com/news/addstorycomment.aspx?st=96502305&Channel_ID=22&Category_ID=1342009-11-26T02:14:00CALGARY, AB, Nov. 23 /PRNewswire-FirstCall/ -- Oncolytics Biotech Inc. ('Oncolytics' or the 'Company') (TSX:ONC; NASDAQ:ONCY) announced today that it has closed its previously announced US$12,750,000 Pharma LiveHuman Genome Sciences Begins Tumor Treatment Trialhttp://www.congoo.com/news/addstorycomment.aspx?st=96464204&Channel_ID=22&Category_ID=1342009-11-26T00:11:00Recently, Human Genome Sciences, Inc. (HGSI) An additional phase I clinical trial of the compound is being conducted to evaluate its safety and tolerability in patients with advanced solid tumors. Earlier Seeking AlphaFMC Corporation Executives to Address Investors at December Conferenceshttp://www.congoo.com/news/addstorycomment.aspx?st=96368789&Channel_ID=22&Category_ID=1342009-11-26T06:38:00PHILADELPHIA, Nov. 25 /PRNewswire-FirstCall/ -- FMC Corporation (NYSE: FMC) announced today that it will be presenting at two investor conferences in December at which its executives will provide an overview KOTA Territory NewsAmbit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and http://www.congoo.com/news/addstorycomment.aspx?st=96344944&Channel_ID=22&Category_ID=1342009-11-26T05:34:00SAN DIEGO, Nov. 24 /PRNewswire/ -- Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the 51st KOTA Territory NewsResearchers at Signature Genomics Attribute Diverse Spectrum of Neurological Problems http://www.congoo.com/news/addstorycomment.aspx?st=96548042&Channel_ID=22&Category_ID=1342009-11-26T07:23:00- Researchers at Signature Genomic Laboratories, which performs diagnostic genetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities, including Pharma LiveEcho Therapeutics to Present at the New York Society of Security Analysts' 13th http://www.congoo.com/news/addstorycomment.aspx?st=96399809&Channel_ID=22&Category_ID=1342009-11-26T05:34:00FRANKLIN, Mass., Nov. 24 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal KOTA Territory NewsSigma-Aldrich to Present at the NASDAQ OMX 23rd Investor Program on Tuesday, December http://www.congoo.com/news/addstorycomment.aspx?st=96328510&Channel_ID=22&Category_ID=1342009-11-26T05:34:00ST. LOUIS, Nov. 24 /PRNewswire-FirstCall/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) will be presenting at the NASDAQ OMX conference on Tuesday, December 1st at 1:45 PM GMT in London, 7:45 AM US/CST. KOTA Territory NewsNovartis Corporation (NVS) (JOBS) Strikes Potential $1.1 Billion Licensing Deal http://www.congoo.com/news/addstorycomment.aspx?st=96533794&Channel_ID=22&Category_ID=1342009-11-26T04:19:00Potential $1.1 Billion Licensing Deal with , , gaJsHost (('https:' ? 'https://ssl.' : + gaJsHost + 'googleanalytics.com/ga.js' pageTracker BioSpace Enter your BioSpace account email address and password BioSpaceSinovac Biotech Ltd. (SNVBF) Establishes Joint Venture to Expand Human-Use Vaccine http://www.congoo.com/news/addstorycomment.aspx?st=96533632&Channel_ID=22&Category_ID=1342009-11-26T04:18:00BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sinovac Biotech Ltd., a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) BioSpaceHow Big Pharma's New Direction Might Help Little Biotechhttp://www.congoo.com/news/addstorycomment.aspx?st=96533467&Channel_ID=22&Category_ID=1342009-11-26T04:17:00San Diego emerged as a winner last week when pharma behemoth Pfizer formally announced the massive, and longtalkedabout, shakeup of its worldwide research and development operations. Read at ') ') BioSpaceEmployees Say Pfizer Inc. (PFE) Skirts Law on Layoffshttp://www.congoo.com/news/addstorycomment.aspx?st=96483931&Channel_ID=22&Category_ID=1342009-11-26T04:15:00About Biospace| Contact Us | Privacy Statement | Terms of Use Post Your News| Post Event | Post Jobs | Post Company Profile | Advertising Opportunities All News | Breaking News | Featured Stories © 2008 BioSpaceTrials Showed Merck & Co., Inc. (MRK)'s (JOBS) Vioxx Risk 'Years Before Withdrawal', http://www.congoo.com/news/addstorycomment.aspx?st=96444890&Channel_ID=22&Category_ID=1342009-11-26T04:19:00About Biospace| Contact Us | Privacy Statement | Terms of Use Post Your News| Post Event | Post Jobs | Post Company Profile | Advertising Opportunities All News | Breaking News | Featured Stories © 2008 BioSpaceRoche and Junta de Andalucia Department collaborate in medical genome project Deal http://www.congoo.com/news/addstorycomment.aspx?st=96398089&Channel_ID=22&Category_ID=1342009-11-26T04:17:00(Datamonitor Financial Deals Tracker via COMTEX News Network) -- Roche Holding, Ltd., a Swiss healthcare company, and Spain-based Junta de Andalucia Department of Health (JADH) have signed an agreement Quote.com SpainSequenom, Inc. (SQNM) Rumors Fuel Rally, Spark Call Tradinghttp://www.congoo.com/news/addstorycomment.aspx?st=96528619&Channel_ID=22&Category_ID=1342009-11-26T03:12:00Shares of Sequenom, Inc. (SQNM: sentiment, chart, options) skyrocketed on Tuesday, as investors speculated that the diagnostics company will soon release positive data regarding its prenatal Down syndrome Schaeffers ResearchCommittee Approves Delay of Biometric Databasehttp://www.congoo.com/news/addstorycomment.aspx?st=96528352&Channel_ID=22&Category_ID=1342009-11-26T03:10:00Follow Israel news briefs on and (IsraelNN.com) The Knesset??s Joint Committee on Science and Internal Affairs discussed the biometric law on Wednesday and approved a delay of the biometric database Israel National News